BGiordano

TL2 Member · Salzburg, AT

Here for the documentation. Occasionally files a wiki request when a page has drifted out of date.

Joined 24 September 2024 · last posted 2d

79 posts, newest first. Showing up to 150.

PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #28 · Compounds › Oral incretins · 26 Jul 2026 · 2 likes The arithmetic in post #27 is right; the assumption feeding it is the part to check. PIONEER 6 is the cardiovascular outcome trial for oral semaglutide and it enrolled…
Common supplements people ask about, assessed one at a time Replied, post #94 · Practice › Interactions · 25 Jul 2026 · 24 likes Everything in post #91 holds. The case it does not cover is the one I have. Separation timing versus clinically important interaction: a separation timing inconvenience…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #95 · Evidence › Journal club · 21 Jul 2026 · 0 likes Everything in post #91 holds. The case it does not cover is the one I have. My experience of SUSTAIN 6 contradicts the reply above. I am posting it as a data point…
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #22 · Analytics › Mass spectrometry · 19 Jul 2026 · 0 likes Post #18 put the caveat in the right place and I want to underline it. The arithmetic for a doubly charged species is (M + 2 x 1.00728) / 2, and the analogous…
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #83 · Wellbeing › Sleep · 12 Jul 2026 · 1 like This follows post #82 rather than contradicting it. Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy…
Primary endpoint hierarchies and why order matters — one year on Replied, post #39 · Evidence › Trials · 8 Jul 2026 · 0 likes I had read the opposite somewhere and cannot now find where, which tells me something.
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #19 · Analytics › HPLC & UHPLC · 7 Jul 2026 · 0 likes I read the earlier replies on Detection wavelength twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #32 · Practice › Dosing & titration · 2 Jul 2026 · 6 likes This follows post #31 rather than contradicting it. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the…
Why we ask for units every single time, with three examples of what goes wrong Replied, post #87 · Start Here › How to Ask · 1 Jul 2026 · 24 likes Confirming post #84 from a second method, which matters more than confirming it from a second person. A photograph of a vial is rarely useful and a photograph of a…
Molecular mass of semaglutide and why the figure differs between sources Replied, post #89 · Compounds › Semaglutide · 29 Jun 2026 · 10 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
Athletes in weight-category sports: a different risk calculus Replied, post #5 · Clinical › Special populations · 27 Jun 2026 · 1 like Summarising the athletes in weight-category sports thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the…
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #21 · Compounds › Semaglutide · 18 Jun 2026 · 1 like Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #97 · Sourcing › Logistics · 10 Jun 2026 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #39 · Analytics › Method validation · 1 Jun 2026 · 4 likes Post #38 put the caveat in the right place and I want to underline it. Trying to state the Specificity position in a way that someone who disagrees would recognise as…
A checklist for reading a certificate in under two minutes Replied, post #31 · Analytics › COA interpretation · 31 May 2026 · 7 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Follow-up: Prior authorisation: what the criteria usually require Started this topic · Access › Insurance & coverage · 29 May 2026 · 41 likes Prior authorisation: what the criteria usually require — setting out what I have, and where I think it stops being reliable. A methods question rather than a…
Reading a syringe in poor light, and how to avoid needing to — what changed since Replied, post #6 · Devices › Syringes & needles · 24 May 2026 · 0 likes Nothing here is medical advice, and anybody uncertain about technique can have it demonstrated by a nurse or a pharmacist in five minutes, which is a better use of the…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #24 · Compounds › Repair & healing peptides · 12 May 2026 · 23 likes Everything in post #20 holds. The case it does not cover is the one I have. Stability in solution is the practical constraint. Dry, these keep well; reconstituted, the…
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction — one… Replied, post #5 · Compounds › Retatrutide · 11 May 2026 · 15 likes Taking post #4 at face value and following it one step further. Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #32 · Practice › Administration · 26 Apr 2026 · 19 likes Post #31 is right about the mechanism and I think understates the practical bit. Completing a dose: I have looked for the primary source twice and failed twice. Either…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #5 · Evidence › Journal club · 18 Apr 2026 · 0 likes One more thing on STEP 1 that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
Splitting an overlong document into two Replied, post #13 · Documentation › Wiki requests · 14 Apr 2026 · 15 likes Say what would make the page wrong. A page whose failure conditions are stated is much easier to review honestly.
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #69 · Analytics › Mass spectrometry · 10 Apr 2026 · 0 likes A methods point on Charge states rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
Revisiting: Drawing up with one needle and injecting with another Replied, post #65 · Practice › Administration · 7 Apr 2026 · 0 likes Needle length matters less than angle for subcutaneous delivery in most people. A short needle at ninety degrees and a longer one at forty-five put the material in…
Why the timeline is on the right and not the left — what changed since Replied, post #16 · Meta › Site feedback · 6 Apr 2026 · 2 likes Feedback on the trust-level page: it explains what each level unlocks, and not what a member at that level is expected to do differently. The second is what people…
The "under review" status pill and when a moderator applies it Replied, post #34 · Evidence › Preprints · 23 Mar 2026 · 0 likes Adding the measurement that post #31 says would settle it. Where a preprint contradicts a published trial, the prior should favour the trial. Where it extends one, the…
Mass error in ppm: the arithmetic and the caveat Replied, post #6 · Analytics › Mass spectrometry · 11 Feb 2026 · 0 likes Adducts — sodium and potassium especially — shift the observed mass in predictable increments. A report showing an unexplained plus twenty-two is usually showing you a…
Trifluoroacetate content and its consequences Replied, post #89 · Analytics › Impurities & related substances · 5 Feb 2026 · 7 likes Good question, well framed, and I would like to see it answered properly.
Recording a dissent on a document rather than suppressing it Replied, post #3 · Documentation › Doc review · 28 Jan 2026 · 0 likes That is consistent with mine, for whatever one more account is worth.
The most common factual error about semaglutide on the internet — what changed since Replied, post #8 · Compounds › Semaglutide · 16 Jan 2026 · 32 likes Discontinuation rates in the trials are worth reading alongside efficacy and almost never are. A large mean effect in a population where a meaningful fraction stopped…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #13 · Pharmacology › Pharmacokinetics · 11 Jan 2026 · 0 likes Answering the Washout question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #75 · Compounds › Tirzepatide · 11 Dec 2025 · 3 likes Post #73 put the caveat in the right place and I want to underline it. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and…
Guidelines revision: what changed and why — one year on Replied, post #44 · Meta › Announcements · 8 Dec 2025 · 1 like Useful. I have added it to my own notes with the date on it.
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #62 · Compounds › Semaglutide · 5 Dec 2025 · 0 likes Post #59 answers the question as asked. The question underneath it is different. On identity confirmation: a mass close to 4113.6 Da on the intact molecule is…
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #77 · Practice › Reconstitution · 26 Nov 2025 · 4 likes Filter needles are worth considering if you are drawing from a glass ampoule and are pointless overhead for a stoppered vial. The trade is dead volume against…
Tirzepatide molecular mass and the charge states you would expect on ESI — does this… Replied, post #7 · Compounds › Tirzepatide · 25 Nov 2025 · 6 likes Adding the measurement that post #6 says would settle it. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as…
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #14 · Sourcing › Regulatory · 3 Nov 2025 · 25 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
EMA product information as a primary source Replied, post #5 · Regional › European Union · 26 Oct 2025 · 0 likes Shortage notifications are published both centrally and nationally and the two do not always agree, usually because they are describing different things. None of the…
Which panel is worth repeating and which is worth ignoring Replied, post #131 · Clinical › Bloodwork · 7 Oct 2025 · 1 like Worth separating two things that post #129 runs together. General information rather than advice about anyone's care. A single value outside a reference interval, on a…
Cagrilintide's dosing interval and the pharmacokinetics behind it Started this topic · Compounds › Cagrilintide & amylin analogues · 30 Sep 2025 · 0 likes Cagrilintide's dosing interval and the pharmacokinetics behind it — setting out what I have, and where I think it stops being reliable. Putting the numbers in the first…
Can a home kit substitute for a laboratory report? A careful no Replied, post #11 · Analytics › Home & field testing · 13 Sep 2025 · 0 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
Documenting an adverse event properly Replied, post #4 · Safety › Adverse events · 11 Sep 2025 · 16 likes Reporting an adverse event to the national reporting scheme is possible for anybody and does not require a clinician. Those schemes exist to catch what trials could not.
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #17 · Devices › Pens & autoinjectors · 3 Sep 2025 · 0 likes Dose counters: pens show the remaining number of doses. When the counter reaches zero, the pen is empty and cannot deliver more. Noting the counter before injection…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #35 · Evidence › Journal club · 21 Aug 2025 · 26 likes On post #31 — agreed on the reasoning, with one qualification. People arriving without having read it should be welcome and should say so, because a question from…
What this community means by "a source", in practical terms Replied, post #68 · Start Here › Welcome · 12 Aug 2025 · 17 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Warfarin and altered intake: the monitoring argument — the long version Started this topic · Practice › Interactions · 3 Aug 2025 · 9 likes Posting this under the heading it deserves: Warfarin and altered intake: the monitoring argument — the long version Everything below is what sits behind that. A narrow…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #71 · Compounds › Cagrilintide & amylin analogues · 19 Jul 2025 · 26 likes Post #67 and I disagree about the size of the effect, not about the direction. Cagrilintide alone is discussed less than in combination because the published data is…
Sodium, potassium and magnesium when intake drops Replied, post #31 · Nutrition & Training › Hydration & electrolytes · 26 Jun 2025 · 1 like Reduced intake reduces electrolyte intake alongside everything else, which is the mechanism behind most of what gets attributed to the compound here. Happy to be the…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #7 · Practice › Reconstitution · 3 Jun 2025 · 2 likes Decimal-point error is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
Half-life, steady state, and accumulation worked through Replied, post #40 · Pharmacology › Pharmacokinetics · 30 May 2025 · 14 likes Half-life came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Pregnancy as an absolute contraindication Replied, post #77 · Safety › Contraindications · 20 May 2025 · 0 likes Pregnancy appears in the labelling for this class and the position is stated explicitly rather than left to inference. Adding it because I spent an afternoon working it…
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #32 · Evidence › Journal club · 14 May 2025 · 23 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. Reading it again, the caveat matters more than the…
Cost per milligram, computed honestly across formats — the long version Replied, post #96 · Access › Pricing · 11 May 2025 · 19 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
Scheduled maintenance and what will be unavailable Replied, post #129 · Meta › Announcements · 30 Apr 2025 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
Requesting a translation of an existing page Replied, post #9 · Documentation › Wiki requests · 15 Apr 2025 · 21 likes Objections to a request belong in the open, and a request that survives an objection is a stronger page for it.
Carryover and the ghost peak from last week's standard Replied, post #81 · Analytics › HPLC & UHPLC · 11 Apr 2025 · 18 likes Taking post #79 at face value and following it one step further. Injection volume matters because column overload distorts peak shape, and an overloaded main peak can…
Ipamorelin selectivity claims and where they came from Replied, post #26 · Compounds › Secretagogues & GH axis · 5 Apr 2025 · 31 likes Something worth flagging about ipamorelin selectivity claims: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual…
What happens after your first post: likes, trust levels, and why none of it matters much Replied, post #6 · Start Here › Welcome · 22 Mar 2025 · 7 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds. It is…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #47 · Compounds › Semaglutide · 21 Mar 2025 · 4 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
Validating a method you did not develop — does this still hold? Replied, post #79 · Analytics › Method validation · 6 Mar 2025 · 1 like Thank you for the correction. I would rather find out here than later.
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #74 · Compounds › Cagrilintide & amylin analogues · 2 Mar 2025 · 6 likes Clear enough that I do not think I have a follow-up, which is unusual.
Coming back to: What published stability data actually covers, and what it does not Started this topic · Practice › Storage & stability · 1 Mar 2025 · 36 likes The question in the title: What published stability data actually covers, and what it does not I will give what I have already checked below so nobody repeats it.…
Validating a method you did not develop — does this still hold? Replied, post #31 · Analytics › Method validation · 21 Feb 2025 · 26 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #36 · Practice › Reconstitution · 19 Feb 2025 · 19 likes Post #33 is the version of this I will quote in future. One addition. Filter needles are worth considering if you are drawing from a glass ampoule and are pointless…
When to suspect the method rather than the sample Replied, post #84 · Analytics › Method validation · 18 Feb 2025 · 23 likes Agreed, and I will stop repeating the version of this I had been repeating.
Consistent declarations and why they matter more than clever ones Replied, post #45 · Sourcing › Logistics · 17 Feb 2025 · 1 like No disagreement from me. Posting only so the question does not look ignored.
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #47 · Devices › Cold chain · 5 Feb 2025 · 0 likes Post #45 and I disagree about the size of the effect, not about the direction. The interaction between cold chain and the storage question is that a warm transit spends…
What changed in 2026, by region Replied, post #110 · Access › International · 30 Jan 2025 · 0 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Protein density versus volume when you cannot eat much Replied, post #30 · Nutrition & Training › Protein & intake · 28 Jan 2025 · 5 likes Everything in post #26 holds. The case it does not cover is the one I have. The most useful thing anyone has posted about protein density versus volume in this category…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #7 · Compounds › Tirzepatide · 26 Jan 2025 · 23 likes I had written a reply contradicting post #3 and deleted it. Here is what survived. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long.…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #8 · Compounds › Oral incretins · 25 Dec 2024 · 32 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
EMA product information as a primary source — does this still hold? Replied, post #42 · Regional › European Union · 16 Nov 2024 · 0 likes Reimbursement is decided nationally and varies substantially between member states for the same authorised product.
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #36 · Compounds › Tirzepatide · 14 Nov 2024 · 15 likes On the mechanism question specifically: the honest position is that GIP agonism plausibly contributes and that the trial design cannot separate its contribution from…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #88 · Compounds › Other compounds · 2 Nov 2024 · 20 likes Solubility varies far more across this subcategory than within the incretins. A compound that needs a specific diluent or a specific pH is not being difficult; it has a…
Promotion criteria, and the one that stops most nominations Replied, post #83 · Documentation › Doc review · 11 Oct 2024 · 15 likes I had written a reply contradicting post #81 and deleted it. Here is what survived. Checked the promotion criteria claim against the primary source this morning. It…
Chronic kidney disease and the FLOW result Replied, post #39 · Clinical › Comorbidities · 23 Aug 2024 · 12 likes Post-authorisation safety studies are the place where under-studied populations eventually appear, and they are public.
Blind submission and why it changes minds Replied, post #21 · Sourcing › Independent verification · 24 Jul 2024 · 16 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #66 · Practice › Dosing & titration · 8 Jul 2024 · 3 likes I had written a reply contradicting post #64 and deleted it. Here is what survived. The documentation on Splitting a weekly dose is better than this thread and I say…
Where the four-week escalation interval comes from, and what it is not Replied, post #16 · Practice › Dosing & titration · 8 Jun 2024 · 20 likes That is clearer than the version I had in my head. Thank you.